Dahu Health Industry Co., Ltd. Class A

Dahu Health Industry Co., Ltd. Class A

SSSE:600257
4.68
CNY
-0.07
(-1.47%)
0.12EPS
106.01P/E
2.65BMarket Cap
Dahu Health Industry Co., Ltd. Class A
SSE:600257
(Shanghai Stock Exchange)

Recent

price

4.68

P/E

ratio

106.01

div

yld

0.42%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.05
1.22
1.35
1.46
1.6
1.91
2.12
2.07
2.22
2.31
1.95
2.65
2.3
2.93
2.17
1.82
1.89
Revenue per Share
0.17
0.04
0.04
0.36
0.04
0.01
0.01
0.02
0.04
-0.27
0.01
-0.37
-0.15
-0.02
-0.16
0.01
0.05
Basic EPS, GAAP
-0.05
-0.11
-0.03
-0.29
-0.12
0.01
0.02
0.02
-0.14
0.02
-0.1
0.03
0.08
0.35
0.1
0.41
- -
Free Cash Flow per Basic Share
0.06
0.07
0.07
0.08
0.07
0.07
0.05
0.03
0.02
0.02
0.03
0.08
0.04
0.05
0.03
0.02
0.02
Dividend per Share
1.38
1.41
1.45
1.8
1.78
1.75
2.67
2.67
2.69
2.41
2.4
1.97
1.83
1.82
1.66
1.67
1.7
Book Value per Share
0.57
0.68
0.74
1.11
1.08
1.07
2.09
2.11
2.14
1.91
1.54
1.3
1.24
1.27
1.16
1.18
1.19
Tangible Book Value per Share
427
427
427
427
427
424
436
480
481
481
479
487
477
408
481
507
483
Basic Weighted Avg Shares
448
521
575
624
683
809
926
997
1,070
1,112
937
1,292
1,095
1,193
1,044
920
914
Sales/Revenue/Turnover
7.35
7.9
8.51
-8.2
1.46
3.57
3.94
3.57
3.68
-0.93
4.27
7.43
4.44
6.96
5.38
9.05
12.48
Operating Margin (%)
24
22
24
23
24
25
26
25
36
38
26
54
62
63
63
62
- -
Depreciation Expense
71
18
16
154
16
3
6
8
18
-131
4
-180
-71
-8
-77
5
25
Net Income, GAAP
1.58
19.78
15.55
10.78
25.55
53.56
38.48
30.95
38.98
- -
27.94
- -
- -
56.41
- -
45.15
35.14
Effective Tax Rate (%)
15.89
3.42
2.73
24.72
2.34
0.32
0.65
0.83
1.65
-11.78
0.45
-13.94
-6.53
-0.68
-7.37
0.55
2.74
Profit Margin (%)
-12
63
34
290
197
187
687
636
720
615
393
462
387
446
392
444
541
Working Capital
32
15
8
49
35
47
5
1
1
29
213
602
563
543
451
391
474
LT Debt
610
647
659
809
807
797
1,336
1,337
1,353
1,189
1,273
1,075
1,001
1,018
956
990
962
Total Equity
0.09
1.25
1.54
13.13
-0.84
-0.03
0.49
0.77
1.66
- -
1.28
- -
- -
0.72
- -
2.02
- -
Return on Invested Capital (%)
10.58
3.94
3.93
15.51
2.3
1.2
1.4
0.68
1.51
- -
-0.15
- -
- -
-0.55
- -
-0.28
- -
Return on Capital (%)
12.94
2.99
2.57
22.24
2.1
0.35
0.6
0.64
1.37
-10.68
0.36
-17.13
-7.82
-0.93
-9.2
0.63
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
264
250
229
LT Borrowings
93
106
140
LT Finance Leases
350
330
334
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
481
481
481
Market Capitalization
3,157
2,084
2,647

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
902
909
905
Cash, Cash Equivalents & STI
339
308
352
Accounts Receivable, Net
93
133
105
Inventories
420
421
383
Total Current Liabilities
395
405
364
Payables & Accruals
- -
- -
- -
ST Debt
264
250
229
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.06%
-4.66%
3.53%
Free Cash Flow
-68.76%
112.1%
351.65%
Net Income, GAAP
-449.49%
-766.02%
-106.58%
Sales/Revenue/Turnover
2.49%
1.46%
-11.92%
Total Cash Common Dividend
3.95%
19.95%
-26.16%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
208
289
268
280
1,044
2025
151
274
- -
275
920
2026
150
284
205
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.02
-0.01
-0.02
-0.12
-0.16
2025
-0.01
- -
- -
0.01
0.01
2026
-0.01
0.04
0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
0.01
0.03
2025
0.01
0.01
- -
0.01
0.02
2026
- -
- -
- -
- -
- -
Business
Dahu Health Industry Co., Ltd. engages primarily in aquaculture, medical care, wine production, and related health businesses in China. The company breeds, processes, and sells freshwater fish and aquatic products including bighead carp, soft-shelled turtles, turtles, hairy crabs, and organic fish under the Dahu brand; flavored sauces and liquor under the Deshan brand; and pearl powder chips, pearl jewelry, and health products under the Dongting brand, alongside chilled and frozen aquatic products; it also provides rehabilitation and nursing services encompassing neurological, bone and joint, elderly, cardiopulmonary, children's rehabilitation, basic life care, and hospice care, as well as medical care and healthy ingredients. Founded in 1999 and headquartered in Changde, Hunan Province, the company operates mainly in China through segments such as aquaculture, medical, wine, pharmaceutical health, and health food divisions. In recent developments, the company changed its name from Dahu Aquaculture Co., Ltd. to Dahu Health Industry Co., Ltd. in 2025 to reflect its strategic shift toward the broader health industry amid declining aquaculture revenue and growth in medical services and processed products; it agreed to acquire an additional 32% stake in Dongfang Huakang Medical Management Co., Ltd. for CNY 200 million and completed an 8% stake acquisition from Kafu Health Technology Co., Ltd., strengthening its healthcare expansion.